Biotech Values

[dia76ca]

I agree entirely with your assesment of AF. However it is annoying that someone following the trading tactics of Cramer can have a significant impact on small biotechs who struggle financially while trying to help overcome cancer. I am not complaining personally as my YTD gain on PPHM is over 260%. As I expect it to be much larger next year I plan to let it ride. PPHM has chosen to go after some of the toughest cancer indications(Lung and Prostate and 5 other indications) and IMHO is going to produce significant gains in Median Overall Survival. I have always respected those who have made great achievements so I do not apologize for respecting Dr.Thorpe and Dr. Garnick(formerly of Genentech)who are both behind PPHM's programs.